secwatch.observer — SEC 8-K summary
======================================

Issuer:     RespireRx Pharmaceuticals Inc. (—)
CIK:        0000849636
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001493152-23-011123
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RespireRx raises $25,000 via sale of 250 shares of Series I 8% Redeemable Preferred Stock
--------------------------------------------------------------------------------

- Raised $25,000 from two accredited investors for 250 shares of Series I 8% Redeemable Preferred Stock.
- Series I Preferred Stock carries 8% annual dividend payable in shares; redeemable upon events like license payments ≥$15M.
- Preferred stock is not convertible into common stock; transfer restricted except to family or affiliates.
- As of April 4, 2023, common shares outstanding: 144,326,672.
- Issuance exempt from registration under Section 4(a)(2) of the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/849636/000149315223011123/0001493152-23-011123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/849636/000149315223011123/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-011123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer